Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, Follicular

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,371 public trials 203 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Recruiting

Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma

NCT04792502

Conditions: B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

Lifespan Cancer Insitute Providence, Rhode Island, United States

View Trial Details

Recruiting

rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder

NCT05974202

Conditions: Chemically-Induced Disorders, Cocaine Dependence, Cocaine Use, +16 more
Locations: New York State Psychiatric Institute (NYSPI) / Substance Treatment and Research Service (STARS) New York, United States

View Trial Details

Recruiting

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

NCT06149286

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: David Geffen School of Medicine at UCLA Los Angeles, California, United States

Boca Raton Clinical Research (BRCR) Global Plantation, Florida, United States

Indiana University and Comprehensive Cancer Center Indianapolis, Indiana, United States

Hattiesburg Clinic Hattiesburg, Mississippi, United States

View all 171 locations

View Trial Details

Recruiting

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

NCT06980116

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations: LLC ARENSIA Exploratory Medicine Tbilisi, Georgia

IMSP Institute of Oncology, ARENSIA Exploratory Medicine Chisinau, Moldova

Hospital Beata Maria Ana Madrid, Spain

Hospital Fundación Jiménez Diaz Madrid, Spain

View all 17 locations

View Trial Details

Recruiting

A Study to Evaluate the Safety and Efficacy of SCTB35 in Combination With Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma

NCT07562022

Conditions: Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL

NCT06792825

Conditions: Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: Masonic Cancer Center Minneapolis, Minnesota, United States

View Trial Details

Recruiting

Drinking, Acetate, and Stress

NCT06584448

Conditions: Alcohol Drinking, Alcohol Use Disorder, Alcohol Use Disorder, Moderate, in Sustained Remission, +20 more
Locations: The Anlyan Center, 300 Cedar St. New Haven, Connecticut, United States

Yale University New Haven, Connecticut, United States

View Trial Details

Recruiting

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

NCT06340737

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
Locations: Stanford University Palo Alto, California, United States

View Trial Details

Recruiting

Interventions in Mathematics and Cognitive Skills

NCT05201534

Conditions: Behavior, Behavior and Behavior Mechanisms, Behavior, Child, +50 more
Locations: Stanford Cognitive and Systems Neuroscience Laboratory Palo Alto, California, United States

View Trial Details

Recruiting

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

NCT06651177

Conditions: Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Gateway Community Services Jacksonville, Florida, United States

IBIS Behavioral Health Tampa, Florida, United States

Ruth M. Rothstein CORE Center Chicago, Illinois, United States

The Gibson Center for Behavioral Change Cape Girardeau, Missouri, United States

View Trial Details